DataPype: A Fully Automated Unified Software Platform for Computer-Aided Drug Design.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
24 Oct 2023
Historique:
received: 20 07 2023
accepted: 26 09 2023
medline: 30 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: epublish

Résumé

With the advent of computer-aided drug design (CADD), traditional physical testing of thousands of molecules has now been replaced by target-focused drug discovery, where potentially bioactive molecules are predicted by computer software before their physical synthesis. However, despite being a significant breakthrough, CADD still faces various limitations and challenges. The increasing availability of data on small molecules has created a need to streamline the sourcing of data from different databases and automate the processing and cleaning of data into a form that can be used by multiple CADD software applications. Several standalone software packages are available to aid the drug designer, each with its own specific application, requiring specialized knowledge and expertise for optimal use. These applications require their own input and output files, making it a challenge for nonexpert users or multidisciplinary discovery teams. Here, we have developed a new software platform called DataPype, which wraps around these different software packages. It provides a unified automated workflow to search for hit compounds using specialist software. Additionally, multiple virtual screening packages can be used in the one workflow, and if different ways of looking at potential hit compounds all predict the same set of molecules, we have higher confidence that we should make or purchase and test the molecules. Importantly, DataPype can run on computer servers, speeding up the virtual screening for new compounds. Combining access to multiple CADD tools within one interface will enhance the early stage of drug discovery, increase usability, and enable the use of parallel computing.

Identifiants

pubmed: 37901539
doi: 10.1021/acsomega.3c05207
pmc: PMC10601415
doi:

Types de publication

Journal Article

Langues

eng

Pagination

39468-39480

Informations de copyright

© 2023 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

J Chem Inf Model. 2013 Aug 26;53(8):2116-30
pubmed: 23834240
Mol Inform. 2016 Jan;35(1):3-14
pubmed: 27491648
ChemMedChem. 2016 Jan 5;11(1):57-71
pubmed: 26541361
J Med Chem. 2012 Feb 23;55(4):1635-44
pubmed: 22280402
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
J Mol Graph Model. 2008 Sep;27(2):161-9
pubmed: 18485770
J Chem Inf Model. 2019 Jan 28;59(1):18-24
pubmed: 30403855
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
J Chem Inf Model. 2010 Apr 26;50(4):572-84
pubmed: 20235588
Bioorg Med Chem Lett. 2011 Jun 1;21(11):3335-41
pubmed: 21531557
Pharmacol Rev. 2013 Dec 31;66(1):334-95
pubmed: 24381236
Nat Rev Chem. 2022 Apr;6(4):287-295
pubmed: 35783295
J Chem Inf Model. 2020 Sep 28;60(9):4112-4115
pubmed: 32011879
ACS Omega. 2019 Dec 17;5(2):1254-1260
pubmed: 31984283
J Med Chem. 2007 Jan 11;50(1):74-82
pubmed: 17201411
Mol Inform. 2010 May 17;29(5):421-30
pubmed: 27463197
J Med Chem. 2010 Apr 22;53(8):3065-74
pubmed: 20334371
Mol Inform. 2012 Apr;31(3-4):246-58
pubmed: 27477095
Nucleic Acids Res. 2021 Jul 2;49(W1):W326-W335
pubmed: 34023895
J Chem Inf Model. 2020 Sep 28;60(9):4109-4111
pubmed: 32981325
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W522-5
pubmed: 17488841
J Chem Inf Model. 2020 Sep 28;60(9):4296-4310
pubmed: 32271577
J Comput Aided Mol Des. 2006 Mar;20(3):179-90
pubmed: 16841235
Pharmaceuticals (Basel). 2022 Aug 24;15(9):
pubmed: 36145265
J Med Chem. 2012 Jul 26;55(14):6582-94
pubmed: 22716043
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Mol Model. 2017 Jan;23(1):26
pubmed: 28064377
J Chem Inf Model. 2017 Jul 24;57(7):1579-1590
pubmed: 28654262
J Chem Inf Model. 2021 Aug 23;61(8):3835-3845
pubmed: 34270903
Nature. 2020 Apr;580(7805):663-668
pubmed: 32152607
Nature. 2020 Sep;585(7825):357-362
pubmed: 32939066
J Chem Inf Model. 2011 Mar 28;51(3):578-96
pubmed: 21323318
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Nucleic Acids Res. 2015 Jul 1;43(W1):W612-20
pubmed: 25883136
Eur J Med Chem. 2021 Nov 15;224:113705
pubmed: 34303871
Chem Sci. 2023 Jan 10;14(6):1443-1452
pubmed: 36794205
Methods Mol Biol. 2022;2390:1-59
pubmed: 34731463
J Chem Inf Model. 2013 Aug 26;53(8):1893-904
pubmed: 23379370
J Chem Inf Model. 2014 Oct 27;54(10):2953-66
pubmed: 25233256
Nat Protoc. 2022 Mar;17(3):672-697
pubmed: 35121854
J Cheminform. 2021 Sep 25;13(1):73
pubmed: 34563271
Molecules. 2022 Apr 13;27(8):
pubmed: 35458710
Nat Commun. 2023 Jan 7;14(1):114
pubmed: 36611029
Drug Discov Today. 2006 Feb;11(3-4):149-59
pubmed: 16533713
J Mol Graph Model. 2022 Sep;115:108228
pubmed: 35667141
J Biomol Struct Dyn. 2022 Feb;40(3):1316-1330
pubmed: 32964805
J Cheminform. 2015 Jun 22;7:26
pubmed: 26101548
J Med Chem. 2012 Jun 14;55(11):4978-89
pubmed: 22582973
J Chem Inf Model. 2023 Feb 27;63(4):1166-1176
pubmed: 36790087

Auteurs

Mohemmed Faraz Khan (MF)

Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow U.P., 226026, India.

Shubhangi Kandwal (S)

Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Darren Fayne (D)

Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Classifications MeSH